SNCA and Parkinson disease: Other biomarkers, such as alpha-synuclein, DJ-1 protein, nucleotide ligase chain, microRNAs, mitochondrial DNA, and metabolites such as uric acid and dopamine, may be used to enhance diagnostic techniques for Parkinson's disease, which have shown potential in various studies [45].